AGM
CLVS

Alpine Global Management’s Clovis Oncology, Inc. CLVS Stock Holding History

Alpine Global Management’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-45,990
Closed -$125K – 824
2021
Q4 		$125K Buy
+45,990
New +$170K 0.02% 601
2020
Q1 		– Sell
-36,924
Closed -$385K – 498
2019
Q4 		$385K Buy
+36,924
New +$269K 0.08% 194
2018
Q3 		– Sell
-7,465
Closed -$339K – 104
2018
Q2 		$339K Buy
+7,465
New +$363K 0.17% 45

Other funds holding CLVS

N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Alpine Global Management's CLVS Position: Q1 2022 in Review

Alpine Global Management sold out of Clovis Oncology, Inc. (CLVS) in Q1 2022, closing a stake of 45,990 shares — an estimated $125K sold.

Alpine Global Management first reported a position in CLVS in Q2 2018 and held it in 3 quarters. The position peaked at $385K in Q4 2019. 153 funds tracked by Wall St. Rank hold CLVS as of Q1 2022.

  • Alpine Global Management reported no remaining Clovis Oncology, Inc. position as of Q1 2022 after selling out during the quarter.
  • Alpine Global Management sold 45,990 Clovis Oncology, Inc. shares in Q1 2022, an estimated $125K.
  • Alpine Global Management first reported a position in Clovis Oncology, Inc. in Q2 2018 and held it in 3 quarters.
  • Alpine Global Management's Clovis Oncology, Inc. position peaked at $385K in Q4 2019.
  • 153 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q1 2022.

Based on Alpine Global Management's 13F filing for Q1 2022, filed 13 May 2022.